B-MoGen Biotechnologies' Series A Round

B-MoGen Biotechnologies raised a round of funding on May 04, 2016. Investors include Bio-Techne.

B-MoGen Biotechnologies is a genome editing company that was born out of a necessity for better biological research tools. The company has developed methods that employ cutting edge and time-tested ge…

Articles about B-MoGen Biotechnologies' Series A Round: